Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q86XP3
UPID:
DDX42_HUMAN
Alternative names:
DEAD box protein 42; RNA helicase-like protein; RNA helicase-related protein; SF3b DEAD box protein; Splicing factor 3B-associated 125 kDa protein
Alternative UPACC:
Q86XP3; A6NML1; A8KA43; O75619; Q68G51; Q96BK1; Q96HR7; Q9Y3V8
Background:
ATP-dependent RNA helicase DDX42, also known as DEAD box protein 42, plays a crucial role in RNA metabolism. It unwinds partially double-stranded RNAs, facilitating various RNA processes. This protein's activity is modulated by ATP and ADP, with ATP promoting RNA strand separation and ADP encouraging the annealing of complementary strands. DDX42's interaction with TP53BP2 enhances cell survival by mitigating TP53BP2's apoptosis-inducing effects.
Therapeutic significance:
Understanding the role of ATP-dependent RNA helicase DDX42 could open doors to potential therapeutic strategies. Its involvement in RNA processing and cell survival mechanisms positions it as a key target for research aimed at uncovering novel treatments for diseases where RNA metabolism and apoptosis regulation are disrupted.